These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19293048)
21. [Care networks in oncology, an evidence for all?]. Ray-Coquard I; Ducimetière F; Farsi F Bull Cancer; 2013; 100(7-8):650-4. PubMed ID: 24063023 [No Abstract] [Full Text] [Related]
22. [Preface]. Liu L; Chen K; Gao S Zhongguo Fei Ai Za Zhi; 2018 Apr; 21(4):251. PubMed ID: 29587898 [No Abstract] [Full Text] [Related]
23. [Financing for rare or orphan diseases: a thing to do]. Hernández-Vásquez A; Rubilar-González J; Pisfil-Benites N Rev Peru Med Exp Salud Publica; 2014 Apr; 31(2):393. PubMed ID: 25123886 [No Abstract] [Full Text] [Related]
24. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience. Pashankar FD; Rodriguez-Galindo C; Pappo A J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404 [TBL] [Abstract][Full Text] [Related]
25. A structured approach to uncommon cancers: what should a clinician do? Raghavan D Ann Oncol; 2013 Dec; 24(12):2932-4. PubMed ID: 24192449 [No Abstract] [Full Text] [Related]
26. [Benefit assessment in special situations--rare diseases]. Windeler J; Lange S Z Evid Fortbild Qual Gesundhwes; 2008; 102(1):25-30. PubMed ID: 19009938 [TBL] [Abstract][Full Text] [Related]
27. Networking in rare cancers: What was done, what's next. Frezza AM; Trama A; Blay JY; Casali PG Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758 [TBL] [Abstract][Full Text] [Related]
28. Clinical trial design for rare cancers: why a less conventional route may be required. Panageas KS Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109 [TBL] [Abstract][Full Text] [Related]
29. Genome project aims to transform treatment of cancer and rare diseases. Godlee R BMJ; 2014 Aug; 349():g4972. PubMed ID: 25085691 [No Abstract] [Full Text] [Related]
30. Genetics of personalized medicine: cancer and rare diseases. Alves ITS; Condinho M; Custódio S; Pereira BF; Fernandes R; Gonçalves V; da Costa PJ; Lacerda R; Marques AR; Martins-Dias P; Nogueira GR; Neves AR; Pinho P; Rodrigues R; Rolo E; Silva J; Travessa A; Leite RP; Sousa A; Romão L Cell Oncol (Dordr); 2018 Jun; 41(3):335-341. PubMed ID: 29633150 [TBL] [Abstract][Full Text] [Related]
32. Introduction: gene and cell therapy projects of the seventh framework program. Gancberg D; Norstedt I; Draghia-Akli R Hum Gene Ther Clin Dev; 2014 Jun; 25(2):51. PubMed ID: 24933558 [No Abstract] [Full Text] [Related]
33. The challenge of very rare tumours in childhood: the Italian TREP project. Ferrari A; Bisogno G; De Salvo GL; Indolfi P; Perilongo G; Cecchetto G; ; Eur J Cancer; 2007 Mar; 43(4):654-9. PubMed ID: 17049226 [TBL] [Abstract][Full Text] [Related]
35. [Epidemiology and management of rare paediatric tumours within the framework of the French Society for Children Cancer]. Réguerre Y; Lacour B; André N; Claude L; Hameury F; Lavrand F; Kalfa N; Peuchmaur M; Orbach D Bull Cancer; 2010 Sep; 97(9):1041-5. PubMed ID: 20813657 [TBL] [Abstract][Full Text] [Related]
37. Thyroid cancer is rare. Foreword. Harmer C Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):393. PubMed ID: 20471228 [No Abstract] [Full Text] [Related]
38. A rare tumor: mucinous cystadenocarcinoma of the breast. Witherspoon LE; Oxenhandler RW Am Surg; 2015 Mar; 81(3):E106-8. PubMed ID: 25760182 [No Abstract] [Full Text] [Related]
39. CART-WHEEL.org can facilitate research into rare gynecological tumors. Bae S; Friedlander M; Scott CL Int J Gynecol Cancer; 2011 Dec; 21(9):1517-9. PubMed ID: 22123710 [No Abstract] [Full Text] [Related]
40. A unifying strategy for clinical trials in rare urological malignancy. Nicholson S Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]